These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 11702)
1. [Lactogenic effect of pyrroxan, a Soviet alpha-adrenoblockader]. Kolodina LN; Poskalenko AN; Korkhov VV; Barannikova TA Akush Ginekol (Mosk); 1976 Aug; (8):60-2. PubMed ID: 11702 [No Abstract] [Full Text] [Related]
2. [Treatment of hypertensive forms of late pregnancy toxicosis and the prevention of anomalies in labor with the new Soviet preparation, pyroxan]. Abramchenko VV; Kolodina LN; Korkhov VV; Varfolomieiev DI Pediatr Akus Ginekol; 1979; (6):48-50. PubMed ID: 42869 [No Abstract] [Full Text] [Related]
3. [The Ca2+ reactivity and the subunit composition of myocardial actomyosin during the pyromecaine and pyrroxan treatment of experimental ischemia]. Kaĭfadzhian MA; Dzhanpoladian EG Farmakol Toksikol; 1990; 53(1):27-30. PubMed ID: 1970309 [TBL] [Abstract][Full Text] [Related]
4. [Effect of single administration of adrenergic alpha receptor blockader piroxan on bronchial patency in patients with bronchial asthma]. Zonis IaM; Zonis BIa Ter Arkh; 1981; 53(11):108-10. PubMed ID: 6122273 [No Abstract] [Full Text] [Related]
5. [Pyrroxan therapy of patients with diencephalic epilepsy]. Vorob'ev SP; Gromov SA; Starykh NT Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(11):1732-5. PubMed ID: 4149761 [No Abstract] [Full Text] [Related]
6. [Effect of rausedyl and pyrroxan on autoregulation of cerebral circulation]. Gaevyĭ MD; Pogorelyĭ VE Biull Eksp Biol Med; 1983 Jul; 96(7):56-9. PubMed ID: 6135465 [TBL] [Abstract][Full Text] [Related]
7. [Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane]. Zonis BIa; Brin VB Ter Arkh; 1979; 51(11):28-30. PubMed ID: 42984 [No Abstract] [Full Text] [Related]
13. [Mechanism of the immunosuppressive effect of the adrenoblocker butyroxan on development of the primary immune response]. Perelygina GM; Poliak AI; Bardakhch'ian EA; Siziakina LP Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):72-6. PubMed ID: 6108664 [TBL] [Abstract][Full Text] [Related]
14. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile. Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559 [No Abstract] [Full Text] [Related]
15. Effects of some adrenergic blockers on the abstinence syndrome of addicts to drugs and alcohol. Krylov SS Ann Ist Super Sanita; 1978; 14(1):77-80. PubMed ID: 40502 [TBL] [Abstract][Full Text] [Related]
16. [Trial of using neurotropic preparations (difenin and pyrroxan) for the purpose of prophylactic anticrisis treatment of hypertension]. Kotovskaia ES; Erina EV Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):75-9. PubMed ID: 6124261 [TBL] [Abstract][Full Text] [Related]
17. [Adrenergic component in the hepatotropic, carcinogenic effect of diethylnitrosamine]. Gurkalo VK; Zabezhinskiĭ MA; Pliss GB; Krylov SS Biull Eksp Biol Med; 1977 Apr; 83(4):455-8. PubMed ID: 15687 [TBL] [Abstract][Full Text] [Related]
18. Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations. Jednákovits A; Kovács A; Bódi I; Jaszlits L; Rabloczky G Acta Physiol Hung; 1990; 75 Suppl():157-8. PubMed ID: 1973560 [No Abstract] [Full Text] [Related]
19. Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats. Horváth E; Bódi I; Jaszlits L; Rabloczky G Acta Physiol Hung; 1990; 75 Suppl():145-6. PubMed ID: 1973558 [No Abstract] [Full Text] [Related]
20. Idazoxan and blood gas changes. Raptopoulos D; Koutinas A; Moustardas N; Papasteriadis A Vet Rec; 1988 Jan; 122(2):47. PubMed ID: 2896410 [No Abstract] [Full Text] [Related] [Next] [New Search]